ARGOS-IO system

DEVICE2 trials

Sponsors

Implandata Ophthalmic Products GmbH

Conditions

Chemical BurnsCongenital AniridiaCongenital GlaucomaGraft vs Host DiseasePrimary Open Angle Glaucoma (POAG)Stevens-Johnson Syndrome

Unknown Phase

Safety and Performance Study of the ARGOS-IO (Intraocular) System in Patients With Primary Open Angle Glaucoma (POAG)

CompletedNCT02434692

Implandata Ophthalmic Products GmbHPrimary Open Angle Glaucoma (POAG)

Start: 2014-07-09End: 2017-04-11Updated: 2024-12-12

Safety and Performance Study of the ARGOS-IO System in Patients Undergoing Boston Keratoprosthesis Implantation

CompletedNCT02945176

Implandata Ophthalmic Products GmbHChemical Burns, Congenital Aniridia, Congenital Glaucoma +2

Start: 2015-03-31End: 2017-06-14Updated: 2025-02-27

Related Papers

Telemetric Intraocular Pressure Monitoring after Boston Keratoprosthesis Surgery Using the Eyemate-IO Sensor: Dynamics in the First Year.

2019-03-0520 citations